MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1212/wnl.0000000000005117

Медицинская библиотека · Neurology · 2018

In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms.

Jones David T, Knopman David S, Graff-Radford Jonathan, Syrjanen Jeremy A, Senjem Matthew L, Schwarz Christopher G, Dheel Christina, Wszolek Zbigniew, Rademakers Rosa, Kantarci Kejal, Petersen Ronald C, Jack Clifford R, Lowe Val J, Boeve Bradley F

Клиническое исследованиеСтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To evaluate 18F-AV-1451 tau PET binding among microtubule-associated protein tau (MAPT) mutation carriers.

METHODS

Using a case-control study, we quantitatively and qualitatively compared tau PET scans in 10 symptomatic and 3 asymptomatic MAPT mutation carriers (n = 13, age range 42-67 years) with clinically normal (CN) participants (n = 241, age range 42-67 years) and an Alzheimer disease (AD) dementia cohort (n = 30, age range 52-67 years). Eight participants had MAPT mutations that involved exon 10 (N279K n = 5, S305N n = 2, P301L n = 1) and tend to form 4R tau pathology, and 5 had mutations outside exon 10 (V337M n = 2, R406W n = 3) and tend to form mixed 3R/4R tau pathology.

RESULTS

Tau PET signal was qualitatively and quantitatively different between participants with AD, CN participants, and MAPT mutation carriers, with the greatest signal intensity in those with AD and minimal regional signal in MAPT mutation carries with mutations in exon 10. However, MAPT mutation carriers with mutations outside exon 10 had uptake levels within the AD range, which was significantly higher than both MAPT mutation carriers with mutations in exon 10 and controls.

CONCLUSIONS

Tau PET shows higher magnitude of binding in MAPT mutation carriers who harbor mutations that are more likely to produce AD-like tau pathology (e.g., in our series, the non-exon 10 families tend to accumulate mixed 3R/4R aggregates). Exon 10 splicing determines the balance of 3R and 4R tau isoforms, with some mutations involving exon 10 predisposing to a greater proportion of 4R aggregates and consequently a lower level of AV-1451 binding, as seen in this case series, thus supporting the notion that this tau PET ligand has specific binding properties for AD-like tau pathology.

Для цитирования: Jones David T, Knopman David S, Graff-Radford Jonathan, Syrjanen Jeremy A, Senjem Matthew L, Schwarz Christopher G, Dheel Christina, Wszolek Zbigniew, Rademakers Rosa, Kantarci Kejal, Petersen Ronald C, Jack Clifford R, Lowe Val J, Boeve Bradley F. In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms.. Neurology. 2018. DOI: 10.1212/wnl.0000000000005117.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.